Clinical Trial Update: Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline for Vaping Cessation in Adults Using Nicotine-Containing E Cigarettes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of cytisinicline for vaping cessation in adults using nicotine-containing e-cigarettes; study status is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Cytisinicline

Snippet

Sponsor: Achieve Life Sciences | Conditions: Vaping Cessation | Phase 3 | Status: NOT_YET_RECRUITING